share_log

Seagen and Zai Lab Announce Regional Strategic Collaboration And License Agreement For TIVDAK; Seagen Will Receive An Upfront Payment Of $30M, As Well As Development, Regulatory, And Commercial Milestone Payments, And Tiered Royalties On Sales Of TIVDAK

Seagen and Zai Lab Announce Regional Strategic Collaboration And License Agreement For TIVDAK; Seagen Will Receive An Upfront Payment Of $30M, As Well As Development, Regulatory, And Commercial Milestone Payments, And Tiered Royalties On Sales Of TIVDAK

SeaGen和再鼎醫藥-SB宣佈達成TIVDAK的區域戰略合作和許可協議;Seagen將獲得3000萬美元的預付款,以及開發、監管和商業里程碑付款,以及銷售TIVDAK的分級特許權使用費
Benzinga Real-time News ·  2022/09/27 08:06

Seagen and Zai Lab Announce Regional Strategic Collaboration And License Agreement For TIVDAK; Seagen Will Receive An Upfront Payment Of $30M, As Well As Development, Regulatory, And Commercial Milestone Payments, And Tiered Royalties On Sales Of TIVDAK

SeaGen和再鼎醫藥-SB宣佈達成TIVDAK的區域戰略合作和許可協議;Seagen將獲得3000萬美元的預付款,以及開發、監管和商業里程碑付款,以及銷售TIVDAK的分級特許權使用費

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論